299 related articles for article (PubMed ID: 22246930)
21. p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast.
Harton AM; Wang HH; Schnitt SJ; Jacobs TW
Am J Clin Pathol; 2007 Jul; 128(1):80-5. PubMed ID: 17580273
[TBL] [Abstract][Full Text] [Related]
22. Fine needle aspiration cytologic diagnosis of axillary accessory breast tissue, including its physiologic changes and pathologic lesions.
Das DK; Gupta SK; Mathew SV; Sheikh ZA; al-Rabah NA
Acta Cytol; 1994; 38(2):130-5. PubMed ID: 8147201
[TBL] [Abstract][Full Text] [Related]
23. Implementation of DNA cytometric measurements in fine-needle aspiration biopsy diagnostics of breast disease.
Elzagheid A; Kuopio T; Collan Y
Cancer; 2004 Dec; 102(6):380-8. PubMed ID: 15494977
[TBL] [Abstract][Full Text] [Related]
24. Mastopathic fibroadenoma of the breast: a pitfall of aspiration cytology.
Mori I; Han B; Wang X; Taniguchi E; Nakamura M; Nakamura Y; Bai Y; Kakudo K
Cytopathology; 2006 Oct; 17(5):233-8. PubMed ID: 16961650
[TBL] [Abstract][Full Text] [Related]
25. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of immunocytochemistry using a Breast Marker antibody cocktail targeting P63/cytokeratin7/18/cytokeratin5/14 for fine needle aspiration of the breast: a retrospective cohort study of 139 cases.
Tanaka S; Kanomata N; Teramura K; Wakita K; Kunihisa T; Yano Y; Moriya T; Hayashi Y
Cytopathology; 2016 Dec; 27(6):465-471. PubMed ID: 27060708
[TBL] [Abstract][Full Text] [Related]
27. Fine needle aspiration of breast lesions in women aged 30 and under.
Maygarden SJ; McCall JB; Frable WJ
Acta Cytol; 1991; 35(6):687-94. PubMed ID: 1950316
[TBL] [Abstract][Full Text] [Related]
28. The clinical use of a P63/cytokeratin7/18/cytokeratin5/14 antibody cocktail in diagnostic breast pathology.
Reisenbichler ES; Ross JR; Hameed O
Ann Diagn Pathol; 2014 Dec; 18(6):313-8. PubMed ID: 25224390
[TBL] [Abstract][Full Text] [Related]
29. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
30. Fine needle aspiration biopsy of the breast. Value of nuclear morphometry after different sampling methods.
Elzagheid A; Collan Y
Anal Quant Cytol Histol; 2003 Apr; 25(2):73-80. PubMed ID: 12746975
[TBL] [Abstract][Full Text] [Related]
31. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
Grin A; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2009 Nov; 33(11):1615-23. PubMed ID: 19675450
[TBL] [Abstract][Full Text] [Related]
32. Large-core needle biopsy versus fine-needle aspiration biopsy in solid breast lesions: comparison of costs and diagnostic value.
Vimpeli SM; Saarenmaa I; Huhtala H; Soimakallio S
Acta Radiol; 2008 Oct; 49(8):863-9. PubMed ID: 18618302
[TBL] [Abstract][Full Text] [Related]
33. Fine-needle aspiration of gray zone lesions of the breast: fibroadenoma versus ductal carcinoma.
Jing X; Normolle D; Michael CW
Diagn Cytopathol; 2013 Sep; 41(9):806-11. PubMed ID: 22936545
[TBL] [Abstract][Full Text] [Related]
34. Fine-needle aspiration cytology of mammary fibroadenoma: a comparison of ThinPrep® and cytospin preparations.
Ly TY; Barnes PJ; Macintosh RF
Diagn Cytopathol; 2011 Mar; 39(3):181-7. PubMed ID: 21319319
[TBL] [Abstract][Full Text] [Related]
35. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
36. Cytologic differential diagnosis of papillary pattern in breast aspirates: correlation with histology.
Nayar R; De Frias DV; Bourtsos EP; Sutton V; Bedrossian C
Ann Diagn Pathol; 2001 Feb; 5(1):34-42. PubMed ID: 11172205
[TBL] [Abstract][Full Text] [Related]
37. [Giant-cell reaction in the breast after fine-needle aspiration].
Marucci G; Bondi A; Lorenzini P; Eusebi V
Pathologica; 2001 Feb; 93(1):15-9. PubMed ID: 11294013
[TBL] [Abstract][Full Text] [Related]
38. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
Cancer; 2003 Jun; 99(3):172-9. PubMed ID: 12811858
[TBL] [Abstract][Full Text] [Related]
39. Cell Block-Based Two-Dimensional and Immunocytochemical Analyses Could Reduce Atypical/Indeterminate Case Frequency in Breast Fine-Needle Aspiration Cytology: A Retrospective Analysis.
Noda Y; Nakanishi Y; Tsuta K; Inaji H; Yamasaki M
Acta Cytol; 2023; 67(6):583-592. PubMed ID: 37820610
[TBL] [Abstract][Full Text] [Related]
40. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
